Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Regen BioPharma (RGBP) Other financing activities (2016 - 2017)

Regen BioPharma (RGBP) has disclosed Other financing activities for 3 consecutive years, with $3340.0 as the latest value for Q1 2017.

  • On a quarterly basis, Other financing activities fell 98.65% to $3340.0 in Q1 2017 year-over-year; TTM through Sep 2017 was $8580.0, a 98.99% decrease, with the full-year FY2017 number at $8580.0, down 98.99% from a year prior.
  • Other financing activities was $3340.0 for Q1 2017 at Regen BioPharma, down from $5240.0 in the prior quarter.
  • In the past five years, Other financing activities ranged from a high of $247739.0 in Q1 2016 to a low of $3340.0 in Q1 2017.
  • A 3-year average of $165136.0 and a median of $247587.0 in 2015 define the central range for Other financing activities.
  • Peak YoY movement for Other financing activities: skyrocketed 86.83% in 2016, then tumbled 98.65% in 2017.
  • Regen BioPharma's Other financing activities stood at $247723.0 in 2015, then tumbled by 97.88% to $5240.0 in 2016, then plummeted by 36.26% to $3340.0 in 2017.
  • Per Business Quant, the three most recent readings for RGBP's Other financing activities are $3340.0 (Q1 2017), $5240.0 (Q4 2016), and $106665.0 (Q3 2016).